Driehaus Capital Management »

Aeglea Biotherapeutics shares owned by Driehaus Capital Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Driehaus Capital Management from 13F filings

Historical chart of Driehaus Capital Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Driehaus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Driehaus Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $9.8M 801k 12.25